World

Top 413 largest Companies in the Drug Manufacturers—Specialty & Generic industry in the World by Market Cap

This is the list of the largest public listed companies in the Drug Manufacturers—Specialty & Generic industry in the world by market capitalization with links to their reference stock.

World Drug Manufacturers—Specialty & Generic Industry Analysis
World Top Companies World Companies Analysis

Top Drug Manufacturers—Specialty & Generic Companies in the World as of Jan. 01, 2026

Rank Company Market Cap (USD) Country Sector Industry
181 Jiangxi Synergy Pharmaceutical Co. Ltd $458.5 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
182 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. $451.2 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
183 Cresco Labs, Inc. $450.3 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
184 Sundial Growers Inc. $448.1 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
185 Canopy Growth Corporation $440.9 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
186 Evolus, Inc. $435.6 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
187 ScinoPharm Taiwan Ltd $432.9 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
188 Knight Therapeutics Inc. $429.7 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
189 Hua Medicine $428.6 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
190 Adcock Ingram Holdings Ltd $425.3 M

(July 1, 2025)

 South Africa South African Healthcare South African Drug Manufacturers—Specialty & Generic
191 Daito Pharmaceutical Co.,Ltd. $425.2 M

(Aug. 1, 2021)

 Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
192 Solid Biosciences Inc. $424.6 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
193 Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd $416.8 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
194 Kindred Biosciences, Inc. $414.6 M

(July 1, 2021)

 United States US Healthcare US Drug Manufacturers—Specialty & Generic
195 Alliance Pharma plc $413.8 M

(Jan. 1, 2025)

 United Kingdom UK Healthcare UK Drug Manufacturers—Specialty & Generic
196 Foresee Pharmaceuticals Co. Ltd $404.0 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
197 Ginwa Enterprise $403.9 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
198 Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. $403.7 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
199 Prosegur Cia de Seguridad SA $386.1 M

(July 1, 2025)

 Germany German Healthcare German Drug Manufacturers—Specialty & Generic
200 ShanXi C&Y Pharmaceutical Group Co. Ltd $377.1 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
201 Amryt Pharma plc $372.9 M

(Jan. 1, 2022)

 United Kingdom UK Healthcare UK Drug Manufacturers—Specialty & Generic
202 Adamas Pharmaceuticals, Inc. $371.8 M

(Nov. 1, 2021)

 United States US Healthcare US Drug Manufacturers—Specialty & Generic
203 Beximco Pharmaceuticals Limited $349.7 M Bangladesh Bangladesh Healthcare Bangladesh Drug Manufacturers—Specialty & Generic
204 Zhejiang Xinguang Pharmaceutical Co. Ltd $349.6 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
205 Jacobson Pharma Corp Ltd $346.9 M Hong Kong HK Healthcare HK Drug Manufacturers—Specialty & Generic
206 Standard Chem & Pharm CO. Ltd $340.5 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
207 Dong-A ST Co. Ltd $327.8 M South Korea South Korean Healthcare South Korean Drug Manufacturers—Specialty & Generic
208 Golden Throat Holdings Group Company Ltd $323.0 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
209 Relmada Therapeutics, Inc. $320.5 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
210 Probi AB $311.3 M

(July 1, 2024)

 Sweden Swedish Healthcare Swedish Drug Manufacturers—Specialty & Generic

Top Drug Manufacturers—Specialty & Generic Companies in the World as of Jan. 01, 2026

181. Jiangxi Synergy Pharmaceutical Co. Ltd

Company Profile: Jiangxi Synergy Pharmaceutical Co. Ltd
Market Cap (USD): $458.5 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

182. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.

Company Profile: Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
Market Cap (USD): $451.2 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

183. Cresco Labs, Inc.

Company Profile: Cresco Labs, Inc.
Market Cap (USD): $450.3 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

184. Sundial Growers Inc.

Company Profile: Sundial Growers Inc.
Market Cap (USD): $448.1 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

185. Canopy Growth Corporation

Company Profile: Canopy Growth Corporation
Market Cap (USD): $440.9 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

186. Evolus, Inc.

Company Profile: Evolus, Inc.
Market Cap (USD): $435.6 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

187. ScinoPharm Taiwan Ltd

Company Profile: ScinoPharm Taiwan Ltd
Market Cap (USD): $432.9 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

188. Knight Therapeutics Inc.

Company Profile: Knight Therapeutics Inc.
Market Cap (USD): $429.7 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

189. Hua Medicine

Company Profile: Hua Medicine
Market Cap (USD): $428.6 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

190. Adcock Ingram Holdings Ltd

Company Profile: Adcock Ingram Holdings Ltd
Market Cap (USD): $425.3 M (July 1, 2025)
Country: South Africa
Sector: South African Healthcare
Industry: South African Drug Manufacturers—Specialty & Generic

191. Daito Pharmaceutical Co.,Ltd.

Company Profile: Daito Pharmaceutical Co.,Ltd.
Market Cap (USD): $425.2 M (Aug. 1, 2021)
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

192. Solid Biosciences Inc.

Company Profile: Solid Biosciences Inc.
Market Cap (USD): $424.6 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

193. Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd

Company Profile: Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd
Market Cap (USD): $416.8 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

194. Kindred Biosciences, Inc.

Company Profile: Kindred Biosciences, Inc.
Market Cap (USD): $414.6 M (July 1, 2021)
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

195. Alliance Pharma plc

Company Profile: Alliance Pharma plc
Market Cap (USD): $413.8 M (Jan. 1, 2025)
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Drug Manufacturers—Specialty & Generic

196. Foresee Pharmaceuticals Co. Ltd

Company Profile: Foresee Pharmaceuticals Co. Ltd
Market Cap (USD): $404.0 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

197. Ginwa Enterprise

Company Profile: Ginwa Enterprise
Market Cap (USD): $403.9 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

198. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

Company Profile: Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.
Market Cap (USD): $403.7 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

199. Prosegur Cia de Seguridad SA

Company Profile: Prosegur Cia de Seguridad SA
Market Cap (USD): $386.1 M (July 1, 2025)
Country: Germany
Sector: German Healthcare
Industry: German Drug Manufacturers—Specialty & Generic

200. ShanXi C&Y Pharmaceutical Group Co. Ltd

Company Profile: ShanXi C&Y Pharmaceutical Group Co. Ltd
Market Cap (USD): $377.1 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

201. Amryt Pharma plc

Company Profile: Amryt Pharma plc
Market Cap (USD): $372.9 M (Jan. 1, 2022)
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Drug Manufacturers—Specialty & Generic

202. Adamas Pharmaceuticals, Inc.

Company Profile: Adamas Pharmaceuticals, Inc.
Market Cap (USD): $371.8 M (Nov. 1, 2021)
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

203. Beximco Pharmaceuticals Limited

Company Profile: Beximco Pharmaceuticals Limited
Market Cap (USD): $349.7 M
Country: Bangladesh
Sector: Bangladesh Healthcare
Industry: Bangladesh Drug Manufacturers—Specialty & Generic

204. Zhejiang Xinguang Pharmaceutical Co. Ltd

Company Profile: Zhejiang Xinguang Pharmaceutical Co. Ltd
Market Cap (USD): $349.6 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

205. Jacobson Pharma Corp Ltd

Company Profile: Jacobson Pharma Corp Ltd
Market Cap (USD): $346.9 M
Country: Hong Kong
Sector: HK Healthcare
Industry: HK Drug Manufacturers—Specialty & Generic

206. Standard Chem & Pharm CO. Ltd

Company Profile: Standard Chem & Pharm CO. Ltd
Market Cap (USD): $340.5 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

207. Dong-A ST Co. Ltd

Company Profile: Dong-A ST Co. Ltd
Market Cap (USD): $327.8 M
Country: South Korea
Sector: South Korean Healthcare
Industry: South Korean Drug Manufacturers—Specialty & Generic

208. Golden Throat Holdings Group Company Ltd

Company Profile: Golden Throat Holdings Group Company Ltd
Market Cap (USD): $323.0 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

209. Relmada Therapeutics, Inc.

Company Profile: Relmada Therapeutics, Inc.
Market Cap (USD): $320.5 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

210. Probi AB

Company Profile: Probi AB
Market Cap (USD): $311.3 M (July 1, 2024)
Country: Sweden
Sector: Swedish Healthcare
Industry: Swedish Drug Manufacturers—Specialty & Generic

Stay in touch